Research Paper Volume 12, Issue 15 pp 15514—15531

Ubiquinol supplementation in elderly patients undergoing aortic valve replacement: biochemical and clinical aspects

Figure 6. Percentage of ejection fraction in placebo (grey) and QH treated (black) group in phase 1 and following 6-month follow-up. **p≤0.01 significance of differences in each experimental group in comparison with phase 1; + p≤0.05 significance of differences between both groups in the follow-up.